1990
DOI: 10.1111/j.2042-7158.1990.tb05349.x
|View full text |Cite
|
Sign up to set email alerts
|

Improved synthetic routes to the novel thromboxane receptor antagonist ICI 192605: activity of synthetic 1,3-dioxane intermediates

Abstract: A study of the synthetic routes to the thromboxane receptor antagonist ICI 192605 4(Z)-6-(2-o-chlorophenyl-4-o-hydroxyphenyl-1,3-dioxan-cis-5-yl) hexenoic acid is described which led to an improvement in overall synthetic yield from 20 to 55%. Invitro thromboxane receptor antagonist data are reported for the novel 1,3-dioxane synthetic intermediates. These data indicated that shortening of the side chain in an appropriately substituted 2,2-dimethyl-1,3-dioxane (e.g. ICI 180080) from a heptenoic acid, to a hexe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1991
1991
2004
2004

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 6 publications
0
1
0
Order By: Relevance
“…ICI 192605 is a highly selective TP receptor blocker with p A 2 of approximately 8 ( Brewster et al , 1988 ; Brown et al , 1990 ). In the present study, 8‐ iso PGE 2 ‐evoked contractions were markedly and significantly reduced by 10 −8 M ICI 192605, and abolished when the concentration of this blocker was increased 10‐fold (Figures 3 and 4), indicating that they are likely directed through TP receptors.…”
Section: Resultsmentioning
confidence: 99%
“…ICI 192605 is a highly selective TP receptor blocker with p A 2 of approximately 8 ( Brewster et al , 1988 ; Brown et al , 1990 ). In the present study, 8‐ iso PGE 2 ‐evoked contractions were markedly and significantly reduced by 10 −8 M ICI 192605, and abolished when the concentration of this blocker was increased 10‐fold (Figures 3 and 4), indicating that they are likely directed through TP receptors.…”
Section: Resultsmentioning
confidence: 99%